To provide theoretical basis and reference for medical workers in the field of kidney transplantation in China in terms of vaccination in kidney transplant candidates and recipients, so as to better guide the kidney transplant candidates and recipients in vaccination, thereby reducing the risk of post-operative infection, and improving the survival.

Enhanced Recovery After Surgery (ERAS) accelerates postoperative recovery by optimizing peri-operative management to reduce surgical stress and inflammatory responses. The ERAS concept has been widely implemented in various surgical fields such as colorectal surgery, obstetrics and gynecology, thoracic surgery, and orthopedics. Although the implementation of ERAS protocol in urogynecologic surgery started relatively late, there has been considerable clinical practice and experience in recent years. In this context, in 2022, the International Urogynecology Association (IUGA) and the American Urogynecology Society (AUGS) jointly published a consensus to promote the application of the ERAS concept in gynecological pelvic floor surgery. To align with international standards, in March 2024, the Pelvic Floor Study Group of the Chinese Medical Association Obstetrics and Gynecology Branch initiated the development of the "Chinese Expert Consensus on Accelerated Recovery of Gynecological Pelvic Floor Surgery," aiming to promote the scientific, standardized, and orderly implementation of ERAS pathways in the field of urogynecologic surgery in China.

In order to improve the safety of thyroid and parathyroid surgery, parathyroid autofluorescence and indocyanine green fluorescence imaging techniques were standardized

Uterine fibroids are the most common benign tumors of the female reproductive system, with an incidence of approximately 40% to 50% among women older than 35 years of age. With the improvement of contemporary health awareness and the progress of ultrasound technology, the detection rate of uterine fibroids has increased, and the age of first diagnosis has been advanced. The treatment of uterine fibroids in women of childbearing age mostly chooses myomectomy to retain reproductive function, but they often face the problem of rehabilitation and fibroid recurrence after surgery. According to statistics, the recurrence rate of uterine fibroids within 3 years after surgery is about 4%-40%. How to promote the rapid recovery of patients after surgery and reduce the recurrence rate of fibroids has become a new proposition in the field of gynecology. As a treasure of the Chinese nation, traditional Chinese medicine (TCM) has been extensively explored in the postoperative treatment of uterine fibroids, and its efficacy has been confirmed in clinical practice. However, there is still a lack of consistent treatment programs, and the clinical application is relatively chaotic. The purpose of this standard is to comprehensively summarize the research results and clinical practice experience of TCM in the postoperative treatment of uterine fibroids, formulate a standardized TCM treatment standard after uterine myomectomy, and provide reference for clinicians.

Extracorporeal shock wave therapy (ESWT) is a widely used non-invasive, safe, and effective treatment method in various clinical fields. In 2019, the Shockwave Medicine Committee of the Chinese Research Hospital Association released the first edition of the "Chinese Extracorporeal Shock Wave Therapy Guidelines for Musculoskeletal Diseases," which was updated in 2023. The Physical Medicine and Rehabilitation Branch of the Chinese Medical Association established the "Expert Consensus on Extracorporeal Shock Wave Therapy for Musculoskeletal Diseases" in 2019. In 2023, pain experts in China developed the "Expert Consensus on Clinical Application of Extracorporeal Shock Wave Therapy by Pain Experts in China." These guidelines have significantly contributed to standardizing ESWT's promotion and application within China. However, current expert consensus and clinical guidelines primarily focus on using ESWT for musculoskeletal diseases and chronic pain conditions, with less attention given to its application for muscle spasms, especially among children where there is no unified approach to key clinical techniques and treatment plans. Over recent years, as ESWT has been increasingly utilized in pediatric rehabilitation medicine, numerous new treatment experiences and research findings have emerged that continuously enhance the clinical evidence supporting ESWT's effectiveness in treating muscle spasms among children. Recognizing this progress, a collaboration between the Pediatric Rehabilitation Committee of China Association Rehabilitation Medicine and Shockwave Medicine Committee of Chinese Research Hospital Association led to formulating "Clinical Practice Guideline for Extracorporeal Shockwave Therapy of Muscle Spasticity in Children (2024)." This guideline aims to offer evidence-based support to practitioners specializing in pediatric rehabilitation, neurology, orthopedics when applying ESWT to treat muscle spasticity among children while promoting more standardized use of ESWT.